Calton & Associates’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,733
Closed -$118K 273
2022
Q4
$118K Buy
5,733
+131
+2% +$2.64K 0.05% 268
2022
Q3
$100K Sell
5,602
-6,182
-52% -$126K 0.06% 202
2022
Q2
$231K Buy
11,784
+79
+0.7% +$1.66K 0.13% 189
2022
Q1
$258K Buy
11,705
+2,096
+22% +$46.9K 0.08% 285
2021
Q4
$215K Buy
9,609
+316
+3% +$7K 0.06% 339
2021
Q3
$196K Buy
9,293
+267
+3% +$5.64K 0.04% 381
2021
Q2
$181K Buy
9,026
+968
+12% +$19.4K 0.03% 389
2021
Q1
$150K Buy
8,058
+273
+4% +$4.91K 0.03% 385
2020
Q4
$130K Buy
7,785
+1,829
+31% +$28.4K 0.02% 370
2020
Q3
$86K Buy
+5,956
New +$85.1K 0.02% 335
2020
Q2
Sell
-3,450
Closed -$34K 351
2020
Q1
$34K Buy
+3,450
New +$50.3K 0.01% 299

Other funds holding OCSL

Calton & Associates's OCSL Position: Q1 2023 in Review

Calton & Associates sold out of Oaktree Specialty Lending (OCSL) in Q1 2023, closing a stake of 5,733 shares — an estimated $118K sold.

Calton & Associates first reported a position in OCSL in Q1 2020 and held it in 11 quarters. The position peaked at $258K in Q1 2022. 185 funds tracked by Wall St. Rank hold OCSL as of Q1 2023.

  • Calton & Associates reported no remaining Oaktree Specialty Lending position as of Q1 2023 after selling out during the quarter.
  • Calton & Associates sold 5,733 Oaktree Specialty Lending shares in Q1 2023, an estimated $118K.
  • Calton & Associates first reported a position in Oaktree Specialty Lending in Q1 2020 and held it in 11 quarters.
  • Calton & Associates's Oaktree Specialty Lending position peaked at $258K in Q1 2022.
  • 185 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q1 2023.

Based on Calton & Associates's 13F filing for Q1 2023, filed 19 Apr 2023.